Please join us for the AI Hype & Hope Lunch and Learn
As AI rapidly transforms industries, it offers groundbreaking opportunities but also introduces complex legal and operational challenges. Professionals, particularly those in restructuring and corporate law, are now facing new concerns around data privacy, regulatory compliance, and the role of AI in decision-making processes. Yet, AI also presents incredible potential for optimizing performance and driving innovation within organizations.
Join us for an exclusive panel where Kevin Neuman, Principal and Healthcare Practice Leader at Novo Advisors, will lead a discussion on AI's impact on restructuring, particularly in healthcare, from both legal and operational perspectives. He will be joined by Ronald Rerko, Practice Director of Healthcare & Life Sciences at Onix Networking Corp, Dr. Galina Datskovsky, a computer scientist specializing in AI and board member at OpenAxes, and Kevin Michael Mooney, a seasoned attorney with over 25 years of experience in technology, cyber, intellectual property, and AI.
Together, they will explore key legal theories relevant to AI, including intellectual property, privacy, confidentiality, contractual obligations, and existing regulations. The panel will also cover future-proofing AI models, considering global regulatory pressures, and share practical tips to mitigate legal risks, such as liability concerns and third-party integrations in AI practices.
This is a must-attend session for attorneys and restructuring professionals looking to understand how AI can be harnessed to drive performance improvement while addressing legal risks and ensuring compliance in today’s evolving corporate landscape.
Kevin Neuman - Principal + Healthcare Practice Leader Novo Advisors (Moderator)
Principal at Novo Advisors with expertise in healthcare transformation, especially in non-labor and supply chain. Over 35 years of experience improving performance in healthcare institutions, including AMCs, IDNs, and community hospitals.
Authored “The Five Lever Framework” for supply chain transformation, leading engagements with nearly $1 billion in P&L improvement.
Previously held senior roles at Alvarez and Marsal, Kaufman Hall, and co-founded Perigon, a healthcare business intelligence company.
Frequent contributor to healthcare innovation through thought leadership and client delivery
Dr. Galina Datskovsky Board Member | Open Axes (Panelist)
Dr. Galina Datskovsky, CRM, FAI and serial entrepreneur is an internationally recognized information governance, privacy, compliance and security and artificial intelligence expert. Galina is currently an independent consultant and serves on several start up boards. Previously Galina served as Senior Vice President of Information Governance at Autonomy/HP; and as General Manager of the Information Governance Business Unit and Senior Vice President of Architecture while at CA Technologies. She joined CA in 2006 with the acquisition of MDY Group International, where she was the founder and CEO.
In addition, Galina currently sits on the advisory board of the Executive Woman’s Forum. She is a champion of the entrepreneurial spirit as she has served on the board of multiple startups, assisting with strategy and continues to support the startup community. Galina served as Chair, President, President Elect and Director of ARMA International (2007-2013) and has been widely published in academic journals, speaking frequently for industry organizations worldwide.
Throughout Galina’s career she has been the recipient of numerous awards. Most notably she was designated a Distinguished Engineer while at CA (2006-10), was the recipient of the prestigious Emmet Leahy award (2013) and was named a Fellow of ARMA International (2014) Prior to founding MDY, Galina consulted for IBM and Bell Labs and taught at the Fordham University Graduate School of Business and the Graduate School of Arts and Sciences at Columbia University. She earned her doctoral degree in Artificial Intelligence as well as her masters’ and bachelor’s degrees in Computer Science from Columbia University.
Ronald Rerko - Practice Director Healthcare & Life Sciences Onix Networking Corp (Panelist)
Ron is the Director of Healthcare and Life Sciences for Onix, with over 35 years’ experience in healthcare. Ron works closely with Google Cloud and Amazon Web Services Healthcare divisions to bring cloud-based solutions to healthcare companies and institutions, focusing on AI and cybersecurity. He also is a national and international consultant for healthcare technology, innovative medical services and models and an advisor to investors for healthcare technology and services.
Ron formerly was the Director of the Cleveland Clinic Genomic Medicine Institute under the chair, Charis Eng, MD, PhD, and helped found and develop the Institute. He previously worked with Michael Gorton (co-founder of Teladoc) at Recuro Health developing health platforms for medical insurance companies and employee benefit providers. Ron was a researcher with Sandy Markowitz, MD, PhD, a Howard Hughes Medical Institute principal investigator and first to identify the loss of 15-prostaglandin dehydrogenase, a novel tumor suppressor gene, leading to development of gastrointestinal cancers.
Based on Ron’s discovery, Dr. Markowitz’s lab has generated >$14 million in research funding and a spin-off company, Rodeo Therapeutics Corporation, that was acquired by Amgen in 2021 for >$600 million.
Kevin Michael Mooney, Esq. - Senior Director, Cleveland Clinic Foundation
Attorney & operational leader with 25 years of experience with corporate, technology, cybersecurity, intellectual property, analytics, AI and data governance disciplines, having built and managed both operational and legal teams.
Currently, Kevin leads the Cleveland Clinic Enterprise Data & AI Governance Office engaged in the strategy and operations related to extending and empowering Cleveland Clinic data, process and technology, as well as the organization of key stakeholders for consistent decision making, including governance across key domains (Quantum, AI, Analytics, etc.).
Prior to this role, Kevin served as Chair of the IT/IP Legal Group Practice and heavily engaged in Cleveland Clinic's IT & commercial opportunities. Prior to joining Cleveland Clinic, Kevin served as in house counsel at several entities, specializing in technology, intellectual property and commercial law.
This will be an education luncheon where one can receive 1.25 hours of CLE credit. Lunch will be served for attendees joining live.
There is also a virtual option for attendance. Moderator and panelists will be virtual for this education.
Location: Holland & Knight LLP, 511 Union Street, Suite 2700, Nashville, TN 37219
Time: Noon - 1:30 pm CDT
Parking: There is parking in the building and the 6th Avenue Garage. Both are managed by Metropolis Parking.
Cost: Members Price (Live): $35
Members Price (Virtual): $35
Non-Members Price (Live): $50
Non-Members Price (Virtual): $50
Cost includes includes lunch for in-person attendees.